Insights On Trial Design

  1. An Adept Travel Solution For Clinical Trial Participants 9/29/2023

    Unearth how ConneX simplifies participant retention and engagement by aligning travel arrangements with study and participant needs, all while adhering to sponsor policies and requirements.

  2. Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs 2/20/2025

    Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.

  3. Meeting Diversity Goals Through Smart Trial Design Strategies 11/8/2023

    Delve into strategies for effectively monitoring and reporting progress toward achieving patient diversity objectives.

  4. Patient-Centric Cardiac Monitoring For Decentralized And Hybrid Trials 5/21/2025

    A patient-centric approach to cardiac monitoring is helping to advance data collection and reliability during decentralized and hybrid clinical trials.

  5. Precision Oncology Clinical Trials And Statistics 2024 3/12/2024

    Delve into the latest advancements in clinical trials, targeted therapies, and the promising future of cancer care, uncovering innovative treatments shaping oncology.

  6. When Transcriptomics Meets Drug Repurposing 8/29/2024

    To support drug repurposing, transcriptomics is being used, which involves studying RNA molecules in cells to understand gene expression and identify potential drug targets.

  7. Why Authenticity And Patient Voice Are Critical When Driving Trial Diversity 10/31/2024

    In this session, a panel of experts discussed the importance of engaging local community leaders to build trust in specific clinical studies.

  8. Antibody-Drug Conjugates Clinical Trials 2024 6/3/2024

    Gain comprehensive insights into Antibody-Drug Conjugates (ADCs) with our 2024 clinical trial report, offering a deep dive into new drug developments and market trends shaping cancer treatment.

  9. Regional Comparisons Of Pharmaceutical Regulations 12/18/2023

    Uncover how performance and regulatory expectations differ for regulatory agencies in various markets, influenced by regional drug review trends, approval decisions, and regulatory guidance.

  10. Build Your Diversity Action Plan With AI And Patient Insights 5/29/2024

    Discover how AI and patient insights can help you build a compliant Diversity Action Plan and overcome barriers to achieve diverse clinical trial enrollment.